scholarly journals Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable Diseases

Diagnostics ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. 320
Author(s):  
K. V. Giriraja ◽  
Suman Govindaraj ◽  
H. P. Chandrakumar ◽  
Basanth Ramesh ◽  
Licy Prasad ◽  
...  
Keyword(s):  
Point Of Care ◽  
Extended Period ◽  
Communicable Diseases ◽  
Non Communicable Diseases ◽  
Multiple Parameters ◽  
Individual Point ◽  
Report Data ◽  
Care Technology ◽  
The Cost ◽  
Integrated Device

Non-communicable diseases are the leading cause of death and disability across India, including in the poorest states. Effective disease management, particularly for cardiovascular diseases, requires the tracking of several biochemical and physiological parameters over an extended period of time. Currently, patients must go to diagnostic laboratories and doctors’ clinics or invest in individual point-of-care devices for measuring the required parameters. The cost and inconvenience of current options lead to inconsistent monitoring, which contribute to suboptimal outcomes. Furthermore, managing multiple individual point-of-devices is challenging and helps track some parameters to the exclusion of others. To address these issues, HealthCubed, a primary care technology company, has designed integrated devices that measure blood glucose, hemoglobin, cholesterol, uric acid, blood pressure, capillary oxygen saturation and pulse rate. Here we report data from clinical studies undertaken in healthy subjects establishing the validity of an integrated device for monitoring multiple parameters.

scholarly journals Cost of care of chronic non-communicable diseases in Jamaican patients: the role of obesity

2016 ◽  
Vol 17 (2) ◽  
pp. 81-95
Author(s):  
Christine M. Fray-Aiken ◽  
Rainford J. Wilks ◽  
Abdullahi O. Abdulkadri ◽  
Affette M. McCaw-Binns
Keyword(s):  
Cost Of Illness ◽  
Hospital Setting ◽  
Indirect Costs ◽  
Communicable Diseases ◽  
Cost Of Care ◽  
Total Direct Cost ◽  
Non Communicable Diseases ◽  
Female Patients ◽  
Per Capita ◽  
The Cost

OBJECTIVE: To estimate the economic cost of Chronic Non-Communicable Diseases (CNCDs) and the portion attributable to obesity among patients in Jamaica.METHODS: The cost-of-illness approach was used to estimate the cost of care in a hospital setting in Jamaica for type 2 diabetes mellitus, hypertension, coronary heart disease, stroke, gallbladder disease, breast cancer, colon cancer, osteoarthritis, and high cholesterol. Cost and service utilization data were collected from the hospital records of all patients with these diseases who visited the University Hospital of the West Indies (UHWI) during 2006. Patients were included in the study if they were between15 and 74 years of age and if female, were not pregnant during that year. Costs were categorized as direct or indirect. Direct costs included costs for prescription drugs, consultation visits (emergency and clinic visits), hospitalizations, allied health services, diagnostic and treatment procedures. Indirect costs included costs attributed to premature mortality, disability (permanent and temporary), and absenteeism. Indirect costs were discounted at 3% rate.RESULTS: The sample consisted of 554 patients (40%) males (60%) females. The economic burden of the nine diseases was estimated at US$ 5,672,618 (males 37%; females 63%) and the portion attributable to obesity amounted to US$ 1,157,173 (males 23%; females 77%). Total direct cost was estimated at US$ 3,740,377 with female patients accounting for 69.9% of this cost. Total indirect cost was estimated at US$ 1,932,241 with female patients accounting for 50.6% of this cost. The greater cost among women was not found to be statistically significant. Overall, on a per capita basis, males and females accrued similar costs-of-illness (US$ 9,451.75 vs. US$ 10,758.18).CONCLUSIONS: In a country with per capita GDP of less than US$ 5,300, a per capita annual cost of illness of US$ 10,239 for CNCDs is excessive and has detrimental implications for the health and development of Jamaica.

Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?

2012 ◽  
Vol 1 (3) ◽  
pp. 173-177 ◽  
Author(s):  
Walter Van Dyck ◽  
Gergely Vértes ◽  
Muhilan Palaniappan ◽  
Daniel Gassull ◽  
Prateek Jain ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Cost Effectiveness ◽  
Point Of Care ◽  
Coronary Syndrome ◽  
Point Of Care Technology ◽  
Care Technology ◽  
The Cost

scholarly journals Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Zehra Yonel ◽  
Asma Yahyouche ◽  
Zahra Jalal ◽  
Alistair James ◽  
Thomas Dietrich ◽  
...  
Keyword(s):  
Vitamin D ◽  
Community Pharmacy ◽  
Healthcare Professionals ◽  
Point Of Care ◽  
Communicable Diseases ◽  
Blood Collection ◽  
Point Of Care Testing ◽  
Patient Acceptability ◽  
Non Communicable Diseases ◽  
Finger Prick

Abstract Background Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals’ access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12 months. The objectives of this study were to determine: whether NCD case finding in dental/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone. Methods An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients > 40 years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine/eGFR, Vitamin-D. Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10 cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants. Results Recruitment rates demonstrated that 8 days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease. Conclusions Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients.

A paper microfluidics-based fluorescent lateral flow immunoassay for point-of-care diagnostics of non-communicable diseases

The Analyst ◽  
2019 ◽  
Vol 144 (21) ◽  
pp. 6291-6303 ◽  
Author(s):  
Satheesh Natarajan ◽  
Fengmei Su ◽  
Joseph Jayaraj ◽  
Malay I. Iesh Shah ◽  
Youju Huang
Keyword(s):  
Point Of Care ◽  
Low Cost ◽  
Communicable Diseases ◽  
Lateral Flow ◽  
Lateral Flow Immunoassay ◽  
Paper Microfluidics ◽  
Non Communicable Diseases ◽  
Point Of Care Diagnostics

An easy-to-use, low-cost and portable fluorescent lateral flow immunoassay based on paper microfluidics was developed for the point-of-care diagnosis of non-communicable diseases.

scholarly journals Variation in the Availability and Cost of Essential Medicines for Non-Communicable Diseases in Uganda: a descriptive time series analysis

2020 ◽  
Author(s):  
Mari Armstrong-Hough ◽  
Srish Sharma ◽  
Sandeep P. Kishore ◽  
Ann R Akiteng ◽  
Jeremy I. Schwartz
Keyword(s):  
Descriptive Analysis ◽  
Communicable Diseases ◽  
Essential Medicines ◽  
Cross Sectional ◽  
Middle Income ◽  
Non Communicable Diseases ◽  
For Profit ◽  
Middle Income Countries ◽  
The Cost ◽  
Over Time

AbstractBackgroundAvailability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time.MethodsWe carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases.ResultsAvailability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price.ConclusionsWe conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.

Assessing the cost-effectivenessof the doctor-patient remotemonitoring system of chronic non-communicable diseases

2016 ◽  
Author(s):  
Evgeny Kulikov ◽  
Olga Kobaykova ◽  
Ivan Deev ◽  
Vadim Boykov ◽  
Alexndra Golubeva ◽  
...  
Keyword(s):  
Communicable Diseases ◽  
Non Communicable Diseases ◽  
The Cost

scholarly journals Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis

PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0241555
Author(s):  
Mari Armstrong-Hough ◽  
Srish Sharma ◽  
Sandeep P. Kishore ◽  
Ann R. Akiteng ◽  
Jeremy I. Schwartz
Keyword(s):  
Descriptive Analysis ◽  
Communicable Diseases ◽  
Essential Medicines ◽  
Cross Sectional ◽  
Middle Income ◽  
Non Communicable Diseases ◽  
For Profit ◽  
Middle Income Countries ◽  
The Cost ◽  
Over Time

Background Availability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time. Methods We carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases. Results Availability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price. Conclusions We conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.

Sign in / Sign up

Export Citation Format

Share Document